You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Skin infections

Dupilumab for treating bullous pemphigoid [ID6479]

  • Awaiting development
  • Reference number: GID-TA11615
  • Expected publication date: TBC
  • Project information
  • Project documents

29269-TSID_10640-Dupilumab-for-Bullous-Pemphigoid-V1.0-MAR2024-NON-CONF-.pdf (nihr.ac.uk)

Back to top